Saudi Arabia’s $600 billion U.S. investment commitment is one factor that could drive upside in 2026, though the outlook for ...

FY 2026 earnings are highly anticipated, but the company's demand outlook is troubling. Click here to find out why NVDA stock ...

Nvidia faces major risks from escalating US-China trade tensions, with Chinese competitors rapidly gaining market share. Read ...

Wedbush expects significant value to be unlocked through Tesla’s full self-driving (FSD) technology and the rollout of its ...

Advanced Micro Devices (NASDAQ: AMD) is an important player in the global semiconductor industry as its chips power multiple ...

Stocks are being undercut by trade tensions and concerns about the fiscal outlook.  Comments today from President Trump knocked Apple’s shares down more than -2% and weighed on technology stocks when ...

The gross proceeds from the offering, before deducting the underwriting discounts and commissions and offering expenses payable by Outlook Therapeutics are expected to be approximately $13.0 million.

We recently published a list of Was Jim Cramer Right About These 12 Stocks? In this article, we are going to take a look at ...

Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company focused on enhancing the standard of care for bevacizumab for the treatment of retina diseases, today announced that it has ...

Intel Corporation, Qualcomm Incorporated, Advanced Micro Devices Inc. Read 's Market Analysis on Investing.com ...